Research services to develop and expand the FDA ARGOS

The contract involves providing research services aimed at developing and expanding the FDA ARGOS, a repository containing high-quality regulatory grade next-generation sequencing data. This follow-on effort, scheduled for FY2025, focuses on bioinformatic and biological research to support the creation of a comprehensive database crucial for advancing diagnostics and medical countermeasures. The work is intended to build upon previous early engagement activities and enhance the FDA's capabilities in managing and utilizing genetic sequence information. This initiative is overseen by the Food and Drug Administration under NAICS code 541714, which pertains to research and development in biotechnology. While specific details such as the solicitation number and place of performance remain unspecified, the contract emphasizes the development of critical tools for public health preparedness. Points of contact include an acquisition liaison and a contracting officer whose identity is yet to be determined, with communication primarily routed through the FDA’s acquisition office.